Uveitis Market By 2024
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
<br />
<br />
Asia Pacific (APAC)<br />
Middle East and Africa (MEA)<br />
North America, the largest and fastest growing regional market for uveitis treatment globally, will<br />
retain its dominant position over the assessed period. With over 34% market value share in<br />
<strong>2024</strong>, this regional will possibly account for around US$ 290 Mn. Europe will remain the second<br />
key market with nearly 27% share by the end of forecast period, followed by Asia Pacific.<br />
View Report Table of Contents, Figures, and Tables<br />
The report profiles key market players and highlights their recent activities supporting<br />
market growth.<br />
Allergan, Inc., Novartis AG (ALCON), Valeant Pharmaceuticals International, Inc., AbbVie Inc.,<br />
Eyegate Pharmaceuticals, Inc., Alimera Sciences Inc., and pSivida Corp. are some of the key<br />
players in the global uveitis treatment market.<br />
Request to View Tables of Content @ http://www.persistencemarketresearch.com/marketresearch/uveitis-market/toc<br />
Among these, Allergan, Valeant, and Novartis constitute the most prominent companies.<br />
Eyegate is also actively involved through strategic acquisitions.<br />
<br />
<br />
<br />
Allergan, in 2016, acquired a gene therapy company RetroSense Therapeutics to<br />
enhance the company’s eye care product pipeline. Later, the same year, Allergan<br />
launched an influential uveitis drug Taytulla.<br />
Novartis recently acquired Encore Vision, Inc. in 2016, to strengthen its ophthalmology<br />
pipeline.<br />
Recently in 2015, Eyegate signed a licensing agreement with Valeant for an effective<br />
combination product against uveitis. More recently in 2016, the company announced the<br />
acquisition of Jade Therapeutics, Inc. and stepped into treatment for poorly-served<br />
ophthalmic indications.<br />
Browse Complete Report @ http://www.persistencemarketresearch.com/marketresearch/uveitis-market.asp<br />
About Us:<br />
Persistence <strong>Market</strong> Research (PMR) is a third-platform research firm. Our research model is a<br />
unique collaboration of data analytics and market research methodology to help businesses<br />
achieve optimal performance.<br />
North America Wound Debridement Products <strong>Market</strong> by <strong>2024</strong>
Change language